Cryo-EM reveals how pathogenic bacteria's toxin-defense system assembles

Two toxins and two RNAs locked in a circle, each holding the others in place.
The cryo-EM structure reveals how TenpIN assembles into a closed, symmetrical complex that keeps the bacterial toxin inactive.
Mark

So these bacteria have a built-in kill switch. Why would they do that to themselves?

Mimi

It's not suicide—it's insurance. Under normal conditions, the antitoxin keeps the toxin locked down. But if a phage invades or resources run out, the cell can activate the toxin and shut itself down rather than let the threat spread.

Luke

That's the theory, but I want to be careful here. The paper shows TenpIN provides resistance to some phages, but not all. And phages have evolved ways around it. The system isn't a guaranteed defense.

Mimi

True. But what's new is that we now know these systems are everywhere—over 700 variants found in pathogens. That's a lot more than anyone expected.

Mark

And the structure shows two toxins and two RNAs in a circle. Why that specific arrangement?

Mimi

The two RNA molecules bind the toxins in a head-to-tail pattern, creating a closed ring. It's elegant—each component stabilizes the others. If you disrupt that circle, the whole thing falls apart.

Luke

But here's what we don't know yet: does this arrangement actually matter for how the toxin kills? The paper identifies putative active-site residues based on mutations, but they only tested two of four candidates. The other two didn't lose function when mutated.

Mark

So the active site might be more complex than they think?

Luke

Or those residues serve a different role. The paper is careful not to overstate, but the resolution of the cryo-EM structure—3.9 angstroms—means some details of the RNA are still fuzzy. The researchers themselves note that parts of the RNA couldn't be fully modeled.

Mimi

That's fair. But what matters clinically is that both RNA repeats work independently. That's new. Other systems need both repeats intact.

Mark

Which means if you're trying to design a drug to break the complex, you'd have to account for redundancy.

Mimi

Exactly. And the paper suggests that's the next step—using this structure to design molecules that disrupt the complex and free the toxin.

Luke

Which is promising, but still theoretical. No one has actually done that yet. The paper is structural biology, not drug development.

  • Antibiotic-resistant ESKAPE pathogens — responsible for the majority of hospital infections — carry TenpIN systems that have remained structurally uncharacterized, leaving a critical gap in our understanding of bacterial survival strategies.
  • Cryo-EM imaging resolved the TenpIN complex to 3.9 angstroms, revealing a circular hetero-tetramer of two toxin proteins and two chemically distinct antitoxin RNA molecules holding each other in precise, mutual restraint.
  • The discovery that both RNA repeats independently neutralize the toxin — despite significant structural differences — suggests evolution has built redundancy into the system, making it harder to disable through natural mutation.
  • Targeted mutagenesis pinpointed two specific amino acids, arginine 55 and serine 56, as the active site residues responsible for the toxin's cell-killing function, giving researchers an exact molecular address to target.
  • With over 700 unique TenpIN variants now identified across bacterial and viral genomes, the field is pivoting toward designing small molecules or peptides that could pry the complex apart and unleash the toxin from within — a strategy that could sidestep existing antibiotic resistance entirely.

Long before modern medicine declared war on bacteria, bacteria were already at war with themselves — evolving intricate molecular systems to survive phage attack, starvation, and cellular stress. Researchers have now used cryo-electron microscopy to illuminate the precise architecture of TenpIN, a toxin-antitoxin defense complex found across some of the world's most dangerous antibiotic-resistant pathogens. By mapping the exact shape of this molecular lock-and-key system at near-atomic resolution, scientists have identified the structural vulnerabilities that could one day be exploited to turn a bacterium's own defenses against it.

Bacteria have carried molecular weapons inside themselves long before antibiotics existed. Toxin-antitoxin systems work like a loaded gun held in check by a trigger lock: under normal conditions, the toxin sits dormant, neutralized by its partner. Under stress — starvation, viral attack — the lock releases, and the toxin activates, halting the cell's growth as a survival measure. One family of these systems, called tenpIN, had remained poorly understood until researchers turned cryo-electron microscopy on complexes drawn from several dangerous pathogens, including Salmonella, Shigella, Klebsiella, and E. coli.

What emerged was a tightly organized circular machine: two toxin proteins and two antitoxin RNA molecules arranged head-to-tail, each holding the others in place. The structure resolved sharply enough to distinguish individual amino acids and the precise geometry of RNA helices. Unusually, the two antitoxin RNA molecules — called Rp1 and Rp2 — are structurally distinct rather than near-identical copies of each other. Despite their differences, both fold into stable pseudoknot structures and both independently neutralize the toxin when tested in living bacteria. This redundancy likely offers an evolutionary advantage: if one repeat mutates into dysfunction, the other keeps the system intact.

The structure also revealed where the toxin does its lethal work. A positively charged groove on the toxin's surface attracts the negatively charged RNA backbone of the antitoxin — and the same groove is where the toxin cuts RNA to kill the cell. Mutating two specific residues, arginine 55 and serine 56, abolished the toxin's poisoning ability entirely, pinpointing the active site with precision.

The broader stakes are considerable. A bioinformatic survey recently identified over 700 unique TenpIN variants across bacterial and viral genomes, many residing in ESKAPE pathogens — the bacteria behind most antibiotic-resistant hospital infections. If researchers can design molecules that pry the toxin-antitoxin complex apart, they could trigger bacterial self-destruction from within, bypassing the resistance mechanisms that have already rendered so many conventional antibiotics ineffective. The cryo-EM structure now provides the detailed blueprint needed to attempt exactly that.

Bacteria have been fighting for survival since long before antibiotics existed. One of their most elegant weapons is a system called toxin-antitoxin, a molecular defense that works like a loaded gun kept safe by a trigger lock. Under normal conditions, a protein toxin sits dormant, neutralized by its partner antitoxin. But when stress arrives—starvation, phage attack, or other threats—the lock releases, and the toxin activates, shutting down the cell's growth as a last resort. Scientists have known about these systems for years, but one family of them, called tenpIN, remained largely mysterious.

That changed when researchers used cryo-electron microscopy to peer directly at the three-dimensional structure of a TenpIN complex pulled from several dangerous pathogens. The bacteria they studied—Salmonella enterica, Shigella flexineri, Klebsiella pneumoniae, and Escherichia coli—all carry identical versions of the same TenpN toxin protein. What the team found was a tightly organized machine: two toxin proteins and two antitoxin RNA molecules arranged in a closed circle, each component holding the others in place. The structure resolved to about 3.9 angstroms, sharp enough to see individual amino acids and the precise way RNA helices twist together.

What made this discovery particularly striking was the antitoxin's design. Unlike other well-studied toxin-antitoxin systems, where the antitoxin repeats are nearly identical copies of each other, the TenpIN system uses two distinctly different RNA repeats. The researchers called them Rp1 and Rp2. Despite their differences—Rp2 is three nucleotides shorter than Rp1, and they diverge at multiple positions along their sequence—both repeats fold into stable structures called pseudoknots, and both can independently neutralize the toxin. When the team tested each repeat separately in living bacteria, both rescued cells from the toxin's growth-inhibiting effects. This functional redundancy suggests an evolutionary advantage: if one repeat mutates and loses function, the system still works.

The structure revealed how this molecular partnership actually holds together. The two RNA molecules sit in a head-to-tail arrangement, their single-stranded ends converging at a groove on the toxin protein's surface. That groove, the researchers noted, is electropositive—positively charged—which attracts the negatively charged RNA backbone. This same groove, they hypothesized, is where the toxin does its actual work: cutting RNA to kill the cell. To test this idea, the team mutated four amino acids they predicted were part of the active site. When they changed arginine 55 and serine 56 to alanine, the toxin lost its ability to poison bacteria. The other two mutations had no effect, pinpointing exactly which residues matter.

The broader significance lies in how widespread these systems actually are. A decade ago, researchers had identified only about 25 different tenpIN sequences. A recent bioinformatic survey found over 700 unique versions scattered across bacterial and viral genomes. More troubling, many of these systems appear in ESKAPE pathogens—the acronym for Enterococcus, Staphylococcus aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacteriaceae—bacteria responsible for most antibiotic-resistant infections in hospitals. Understanding how TenpIN works opens a new avenue for fighting these pathogens. If researchers can design small molecules or peptides that pry apart the toxin-antitoxin complex, they could free the toxin inside the cell, triggering its own death. This would be a fundamentally different approach than traditional antibiotics, potentially bypassing resistance mechanisms that have already evolved.

The cryo-EM structure also revealed how TenpIN differs from its cousins in the toxin-antitoxin family. The ToxIN system forms a larger hexameric ring of three toxins and three antitoxins, while CptIN forms a smaller tetramer like TenpIN. Yet TenpN's protein fold resembles ToxN more closely than CptN, suggesting these systems evolved along different paths despite solving the same problem. The antitoxin RNA, by contrast, looks structurally more like CptIN's RNA, with its long loop that runs alongside the main stem like a third strand. These structural echoes hint at deep evolutionary relationships still waiting to be mapped. For now, the immediate payoff is clear: researchers have a detailed blueprint of how one of nature's most widespread bacterial defense systems assembles and functions, and they know exactly where to aim if they want to disarm it.

The TenpIN complex forms a closed cyclic hetero-tetrameric assembly with two toxin proteins and two antitoxin RNA molecules arranged in a head-to-tail fashion.
— Study findings from cryo-EM structural analysis
Both Rp1 and Rp2 antitoxin repeats were able to restore bacterial growth when co-expressed with TenpN independently, indicating functional redundancy in the system.
— Bacterial growth rescue experiments
Contact Us FAQ